ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
플라즈마 분획 시장 규모는 최근 급성장하고 있습니다. 2025년 341억 4,000만 달러에서 2026년에는 376억 3,000만 달러에 이르고, CAGR 10.2%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 면역글로불린 수요 증가, 혈액질환 유병률 증가, 혈장분획기술의 발전, 병원 및 임상 인프라 확충, 혈장유래요법에 대한 인지도 향상 등이 주요 요인으로 작용한 것으로 보입니다.
플라즈마 분획 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 558억 5,000만 달러에 이르고, CAGR은 10.4%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 정밀의료의 보급 확대, 혈장 제조에 AI 통합, 세계 바이오의약품 협업 확대, 혈장 수집 센터에 대한 투자 증가, 신규 혈장 유래 치료제 개발 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 첨단 플라즈마 분획 기술, 바이오의약품 제품 다양화, 품질 관리 및 규제 준수 강화, 위탁생산기관(CMO/CDMO)의 확대, 혈장 제품 공급망 최적화 등이 있습니다.
향후 몇 년 동안 만성 질환의 유병률 증가는 플라즈마 분획 시장의 성장을 견인할 것으로 예측됩니다. 만성질환이란 1년 이상 지속되어 지속적인 의료적 치료가 필요한 병태를 말하며, 대표적인 예로는 심장병, 암, 당뇨병 등을 들 수 있습니다. 혈장 유래 제품에 대한 접근을 통한 만성질환 환자의 치료는 이환율 감소, 삶의 질 향상, 비용 효율적인 치료 접근법 제공에 기여하며, 이는 플라즈마 분획에 대한 수요 증가로 이어질 수 있습니다. 예를 들어, 영국 정부 기관 GOV.UK에 따르면, 2024년 3월 기준 영국 내 17세 이상 성인의 GP(일반의) 기록상 2형 당뇨병 유병률은 7.0%로 2023년 3월의 6.8%에서 상승했습니다. 따라서 모든 연령대에서 만성질환의 부담이 증가함에 따라 혈장분획 시장의 성장을 가속할 것으로 예측됩니다.
시장에서 활동하는 주요 기업들은 기증된 혈장을 필수 의약품으로 전환하기 위해 첨단 시설 공정과 같은 첨단 기술을 채택하여 효율성과 안전성을 향상시키고 있습니다. 예를 들어, 2023년 3월 독일에 본사를 둔 CSL 베링(CSL Bering)은 4억 7,000만 달러를 투자한 새로운 플라즈마 분획 시설을 개설했습니다. 이 시설에는 혈장 처리의 효율성과 안전성을 높이는 최첨단 기술이 도입되어 보다 높은 품질과 신뢰성을 갖춘 의약품을 생산할 수 있습니다. 이러한 중요한 치료제공급을 확대함으로써 증가하는 수요를 지원하고 더 많은 환자들이 생명을 구할 수 있는 치료를 받을 수 있도록 돕고 있습니다. 고도의 자동화 시스템과 자가 세척 시스템을 채택하여 오염 위험을 최소화하고 위생 환경 전반을 개선하여 환자의 안전을 강화하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Plasma fractionation refers to a process that combines multiple manufacturing steps to separate crude plasma fractions, which are then sequentially and systematically refined into specific therapeutic products in an integrated manner.
The primary products in the plasma fractionation market include immunoglobulins, coagulation factors, albumin, and protease inhibitors. Immunoglobulins are used in the treatment of a broad range of conditions, such as primary and secondary immunodeficiencies, autoimmune disorders, and inflammatory diseases. Immunoglobulins (Ig), also known as antibodies, are glycoproteins produced by plasma cells that play a vital role in the immune system by identifying and neutralizing foreign substances, including pathogenic bacteria and viruses. These products are applied across areas such as immunology, hematology, neurology, critical care, hemato-oncology, and rheumatology, and are utilized by end users including hospitals and clinics, clinical research laboratories, and academic institutions.
Tariffs have introduced challenges for the plasma fractionation market by increasing import costs for raw plasma and specialized manufacturing equipment, affecting production efficiency. Segments such as immunoglobulins and coagulation factors are most impacted, particularly in regions like Europe and Asia-Pacific where plasma imports are significant. However, tariffs have also encouraged local production and investments in domestic plasma fractionation facilities, potentially fostering self-sufficiency and innovation within the market.
The plasma fractionation market research report is one of a series of new reports from The Business Research Company that provides plasma fractionation market statistics, including plasma fractionation industry global market size, regional shares, competitors with a plasma fractionation market share, detailed plasma fractionation market segments, market trends and opportunities, and any further data you may need to thrive in the plasma fractionation industry. This plasma fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The plasma fractionation market size has grown rapidly in recent years. It will grow from $34.14 billion in 2025 to $37.63 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growth in demand for immunoglobulins, increased prevalence of hematological disorders, technological advancements in plasma fractionation, expansion of hospital and clinical infrastructure, rise in awareness about plasma-derived therapies.
The plasma fractionation market size is expected to see rapid growth in the next few years. It will grow to $55.85 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, integration of ai in plasma manufacturing, expansion of global biopharmaceutical collaborations, rising investments in plasma collection centers, development of novel plasma-derived therapies. Major trends in the forecast period include advanced plasma fractionation techniques, biopharmaceutical product diversification, enhanced quality control and regulatory compliance, expansion of contract manufacturing organizations (cmos/cdmos), supply chain optimization in plasma products.
The growing prevalence of chronic diseases is expected to drive the expansion of the plasma fractionation market in the coming years. Chronic diseases are conditions that persist for one year or longer and require continuous medical care, with common examples including heart disease, cancer, and diabetes. Treating patients with chronic conditions through access to plasma-derived products helps reduce morbidity, enhance quality of life, and offers a cost-effective therapeutic approach, thereby increasing demand for plasma fractionation. For instance, in March 2025, according to GOV.UK, a UK-based government organization, the prevalence of GP-recorded type 2 diabetes among adults aged 17 and above in England reached 7.0% in March 2024, rising from 6.8% in March 2023. Therefore, the increasing burden of chronic diseases across all age groups is expected to propel the growth of the plasma fractionation market.
Major companies operating in the market are adopting advanced technologies, such as high-tech facility processes, to convert donated human plasma into essential medicines while improving efficiency and safety. For instance, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility valued at $470 million that incorporates state-of-the-art technology to enhance the efficiency and safety of plasma processing, resulting in higher-quality and more dependable medicines. By expanding the supply of these critical therapies, the facility supports the rising demand and helps ensure that a greater number of patients can access life-saving treatments. The use of advanced automation and self-cleaning systems minimizes contamination risks and improves overall hygienic conditions, thereby strengthening patient safety.
In May 2024, LFB, a France-based biopharmaceutical company, acquired Amber Plasma for an undisclosed amount. Through this acquisition, LFB seeks to strengthen its plasma collection network across Europe and expand its capacity to support the manufacturing of plasma-derived therapies. Amber Plasma is a Czech Republic-based company specializing in plasma collection.
Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP
North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the plasma fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The plasma fractionation market includes revenues earned by entities by combining manufacturing steps to isolate, in a sequential and integrated manner. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Plasma Fractionation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses plasma fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for plasma fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plasma fractionation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Immunoglobulins; Coagulation Factors; Albumin; Protease Inhibitors
2) By Application: Immunology; Hematology; Neurology; Critical Care; Hemato-Oncology; Rheumatology
3) By End User: Hospitals and Clinics; Clinical Research Laboratories; Academic Institutes
Subsegments:
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.3 Enhanced Quality Control And Regulatory Compliance
4.2.4 Expansion Of Contract Manufacturing Organizations (Cmos/Cdmos)
4.2.5 Supply Chain Optimization In Plasma Products
5. Plasma Fractionation Market Analysis Of End Use Industries
5.1 Hospitals And Clinics
5.2 Clinical Research Laboratories
5.3 Academic Institutes
5.4 Blood And Plasma Banks
5.5 Pharmaceutical Companies
6. Plasma Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Plasma Fractionation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Plasma Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Plasma Fractionation Market Size, Comparisons And Growth Rate Analysis
7.3. Global Plasma Fractionation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Plasma Fractionation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Plasma Fractionation Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Plasma Fractionation Market Segmentation
9.1. Global Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Plasma Fractionation Market, Sub-Segmentation Of Coagulation Factors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Plasma Fractionation Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Albumin, Bovine Serum Albumin (BSA)
9.7. Global Plasma Fractionation Market, Sub-Segmentation Of Protease Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Plasma Fractionation Market
12.1. China Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Plasma Fractionation Market
13.1. India Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Plasma Fractionation Market
14.1. Japan Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Plasma Fractionation Market
15.1. Australia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Plasma Fractionation Market
16.1. Indonesia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Plasma Fractionation Market
17.1. South Korea Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Plasma Fractionation Market
18.1. Taiwan Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Plasma Fractionation Market
19.1. South East Asia Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Plasma Fractionation Market
20.1. Western Europe Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Plasma Fractionation Market
21.1. UK Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Plasma Fractionation Market
22.1. Germany Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Plasma Fractionation Market
23.1. France Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Plasma Fractionation Market
24.1. Italy Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Plasma Fractionation Market
25.1. Spain Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Plasma Fractionation Market
26.1. Eastern Europe Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Plasma Fractionation Market
27.1. Russia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Plasma Fractionation Market
28.1. North America Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Plasma Fractionation Market
29.1. USA Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Plasma Fractionation Market
30.1. Canada Plasma Fractionation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Plasma Fractionation Market
31.1. South America Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Plasma Fractionation Market
32.1. Brazil Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Plasma Fractionation Market
33.1. Middle East Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Plasma Fractionation Market
34.1. Africa Plasma Fractionation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Plasma Fractionation Market Regulatory and Investment Landscape
36. Plasma Fractionation Market Competitive Landscape And Company Profiles
36.1. Plasma Fractionation Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Plasma Fractionation Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Plasma Fractionation Market Company Profiles
36.3.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. CSL Limited Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Grifols S. A Overview, Products and Services, Strategy and Financial Analysis
37. Plasma Fractionation Market Other Major And Innovative Companies
ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group
38. Global Plasma Fractionation Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Plasma Fractionation Market
40. Plasma Fractionation Market High Potential Countries, Segments and Strategies
40.1 Plasma Fractionation Market In 2030 - Countries Offering Most New Opportunities
40.2 Plasma Fractionation Market In 2030 - Segments Offering Most New Opportunities
40.3 Plasma Fractionation Market In 2030 - Growth Strategies
